FDA warns of heart-related events for arthritis drug Xeljanz and others in its class
By
Alicia Lasek
Sep 02, 2021
The agency is requiring a warning label on the arthritis and ulcerative colitis drugs Xeljanz and Xeljanz XR (tofacitinib) and two other drugs in this class, citing an increased risk of adverse health...
Clinical briefs for Monday, Feb. 8
By
Alicia Lasek
Feb 08, 2021
FDA may further restrict rheumatoid arthritis drug Xeljanz due to safety concerns … Depression, altered use of public transport may signal Parkinson’s a decade early … J&J seeks U.S. approval of...
FDA approves Pfizer’s rheumatoid arthritis treatment
Nov 14, 2012
Federal regulators recently approved Pfizer’s new Xeljanz treatment for rheumatoid arthritis. Xeljanz was approved for patients with moderate to severe rheumatoid arthritis who did not benefit from...
Pfizer gets FDA approval for rheumatoid arthritis treatment
By
McKnight's Staff
Nov 09, 2012
Federal regulators approved Pfizer’s new Xeljanz treatment for rheumatoid arthritis Tuesday. The potentially lucrative drug is now poised to enter a market that already features Humira, Abbott Laboratories’...